Loading...
Persistent corneal epithelial defect responding to rebamipide ophthalmic solution in a patient with diabetes
OBJECTIVE: Rebamipide ophthalmic suspension was developed for the treatment of dry eyes and for other corneal diseases, promoting the secretion of both mucin in tear fluid and membrane-associated mucin, increasing the number of goblet cells, and restoring the barrier function of the corneal epitheli...
Saved in:
| Published in: | Int Med Case Rep J |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4872273/ https://ncbi.nlm.nih.gov/pubmed/27257394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IMCRJ.S103299 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|